Both Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR) are effective NAD+ precursors, but they differ in bioavailability, molecular pathways, and clinical evidence. NMN (CAS 1094-61-7) has shown superior bioavailability in recent studies and directly produces NAD+ in one step. This article compares the two and helps supplement manufacturers make informed sourcing decisions.
This is placeholder content for the blog post. Replace with your full article content. Contact us at [email protected] for more information.